It is a healthcare private limited company based in Delhi, Delhi, India, established in 2006.
2006 | Delhi, Delhi, India | ActiveGalaxy Oncology Associates Private Limited, a active private limited company, was established on 19 October 2006 in Delhi, Delhi, India. Engaging in oncology clinics & cancer treatment within the trade sector, it holds CIN: U85110DL2006PTC154903. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.97 Cr.
It upholds a compliant status. Its leadership includes Umang Mithal (Director), Sandeep Agarwal (Additional Director). Past directors included Arun Kumar Goel, Anand Parkash Sharma, Malay Nandy. It holds ₹11.35 Cr open charges and ₹12.00 Cr settled loans. Its latest AGM occurred on 22 September 2025, with the balance sheet filed on 31 March 2025. It is based at Unit No. 302, Third Floor, Plot No. 9, Vardhman Siddhant Plaza, L.S.C. Savita V, Ihar,, Delhi, Delhi, 110092.
U85110DL2006PTC154903
154903
19 October 2006
₹5.00 Cr
₹4.97 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Galaxy Oncology Associates Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Umang Mithal | Director | 08 Aug 2022 | Current |
| Sandeep Agarwal | Additional Director | 20 Aug 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Mar 2017 | Past |
| Pramod Abcsdd | Company Secretary | 03 Aug 2009 | Past |
| Pramod Abcsdd | Managing Director | 07 Nov 2006 | Past |
| Pramod Abcsdd | Director | 08 Aug 2022 | Past |
| Pramod Abcsdd | Director | 31 Mar 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Galaxy Oncology Associates Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 21.36% decrease. The company also saw a substantial fall in profitability, with a 1544.49% decrease in profit. The company's net worth observed a substantial decline by a decrease of 46.94%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Galaxy Oncology Associates had a promoter holding of 50.13% and a public holding of 49.87%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹113,500,000.00
₹120,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Oct 2025 | Others | ₹7.58 Cr | Open |
| 01 Feb 2023 | Others | ₹1.87 Cr | Open |
| 20 Sep 2022 | Others | ₹1.90 Cr | Open |
| 15 Dec 2007 | Bank Of India | ₹12.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Galaxy Oncology Associates, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Galaxy Oncology Associates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Galaxy Oncology Associates's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 7.58 Cr with Charge ID 101201274 was registered on 29 Oct 2025. was recorded as a recent event.
The activity A charge with Others of Rs. 1.87 Cr registered on 01 Feb 2023 with Charge ID 100686837 was modified on 24 Sep 2025. was completed.
Progress on Galaxy Oncology Associates Private Limited last Annual general meeting of members was held on 22 Sep 2025 as per latest MCA records. was documented.
Progress on Sandeep Agarwal was appointed as a Additional Director was appointed as a Additional Director on 20 Aug 2025 & has been associated with this company since 4 months 30 days . was documented.
Galaxy Oncology Associates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 1.87 Cr with Charge ID 100686837 was registered on 01 Feb 2023. was completed.
The CIN of Galaxy Oncology Associates Private Limited is U85110DL2006PTC154903.
Galaxy Oncology Associates Private Limited is headquartered at Unit No. 302, Third Floor, Plot No. 9, Vardhman Siddhant Plaza, L.S.C. Savita V, Ihar,, Delhi, Delhi, 110092.
Galaxy Oncology Associates Private Limited was incorporated on 19 October 2006.
The current directors of Galaxy Oncology Associates Private Limited are
The primary industry of Galaxy Oncology Associates Private Limited is Trade.
Galaxy Oncology Associates Private Limited is unlisted.
The authorized capital of Galaxy Oncology Associates Private Limited is ₹5.00 Cr, and the paid-up capital is ₹4.97 Cr.
The compliance status of Galaxy Oncology Associates Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX